Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

MingChoo Sep. 13 at 1:02 PM

$SINT Next up2

0 · Reply

et1000 Sep. 11 at 11:31 PM

Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $XHLD $INHD $MNTK $SINT Therap

0 · Reply

FastBull Sep. 11 at 6:53 PM

$SINT seek medical help if you truly believe this company is worth anything at all

0 · Reply

Boston7452 Sep. 8 at 6:23 PM

$SINT $ZBH $SOLV $MMM $TMO Example of a 360 degree Bioshield with "Sintx Inside"

0 · Reply

focafoca99 Sep. 8 at 12:25 PM

$SINT highlights its upcoming presentation at the H.C. Wainwright 28th Annual Global Investment Conference on Sept 14-16. https://www.rapidticker.com/news/sint-sintx-technologies-to-present-at-e4405a

1 · Reply

Boston7452 Sep. 7 at 6:28 PM

$SINT Google AI analysis

0 · Reply

Boston7452 Sep. 7 at 6:03 PM

$SINT What does this suggest?

0 · Reply

Maxandbear Sep. 5 at 1:40 AM

$SINT why are there any people on this feed?

1 · Reply

Boston7452 Sep. 3 at 4:48 PM

$SINT "The Fiduciary Breach (Corporate Waste): Your analysis of SINTX rushing an exceptionally expensive SiNAPTIC medical platform rollout while completely neglecting or hiding high-margin joint-venture opportunities for their core laser-cladding silicon nitride patent portfolio fits a classic corporate waste template"

0 · Reply

Boston7452 Sep. 3 at 3:22 PM

$SINT we agree snoop, they are fraudulent. Regardless Sintx has very important and valuable IP. So remove board and management and put someone in that will actually bring products to market.

0 · Reply

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

2026-08-17T08:25:29.000Z - 27 days ago

Sintx Technologies files to sell 1.27M shares of common stock for holders

Aug 13, 2026, 9:00 AM EDT - 4 weeks ago

SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement

Aug 13, 2026, 8:00 AM EDT - 4 weeks ago

Sintx Technologies Registration statement: Registration filing

Aug 11, 2026, 4:30 PM EDT - 4 weeks ago

Sintx Technologies Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 4 weeks ago

Sintx Technologies Quarterly report: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 4 weeks ago

Sintx Technologies Earnings release: Q2 2026

Aug 11, 2026, 4:06 PM EDT - 4 weeks ago

SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

Jul 28, 2026, 9:00 AM EDT - 6 weeks ago

SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

Jul 23, 2026, 9:00 AM EDT - 7 weeks ago

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Sintx Technologies Registration statement: Registration filing

2026-06-25T10:05:39.000Z - 2 months ago

Sintx Technologies files to sell 5.82M shares of common stock for holders

2026-06-22T14:00:56.000Z - 2 months ago

Sintx Technologies receives $3.2M in purchase orders

Jun 22, 2026, 9:00 AM EDT - 2 months ago

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

Jun 15, 2026, 11:13 AM EDT - 3 months ago

Sintx Technologies Transcript: Transcript

2026-06-04T11:45:10.000Z - 3 months ago

Sintx Technologies resumed with a Buy at Maxim

Jun 3, 2026, 9:00 AM EDT - 3 months ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

May 17, 2026, 3:30 PM EDT - 3 months ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

2026-04-13T10:11:23.000Z - 5 months ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

Mar 23, 2026, 9:15 AM EDT - 5 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

2026-03-19T11:51:39.000Z - 5 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

Mar 19, 2026, 7:30 AM EDT - 5 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

2026-02-18T13:40:31.000Z - 6 months ago

Sintx Technologies appoints Elmore as President

Feb 18, 2026, 8:30 AM EST - 6 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Jan 29, 2026, 9:00 AM EST - 7 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

2025-12-01T13:35:45.000Z - 9 months ago

Sintx Technologies signs supply agreement with EVONIK

Dec 1, 2025, 8:30 AM EST - 9 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

2025-11-13T13:05:19.000Z - 10 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

Nov 13, 2025, 7:00 AM EST - 10 months ago

Sintx Technologies Earnings release: Q3 2025

2025-11-03T13:05:41.000Z - 10 months ago

Sintx Technologies announces launch of OsseoSculpt

Nov 3, 2025, 8:00 AM EST - 10 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

2025-10-23T20:40:36.000Z - 10 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

2025-10-20T11:05:38.000Z - 10 months ago

Sintx receives FDA clearance for SINAPTIC Foot, Ankle implant system

Oct 20, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

2025-10-14T11:11:00.000Z - 11 months ago

Sintx Technologies announces U.S. patent notice of allowance

Oct 14, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

2025-09-30T20:55:10.000Z - 11 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

2025-09-09T02:54:00.000Z - 1 year ago

Why Is Sintx Technologies Stock (SINT) Down 20% Today?

2025-09-08T12:01:04.000Z - 1 year ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

Sep 8, 2025, 7:54 AM EDT - 1 year ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

2025-09-08T11:25:37.000Z - 1 year ago

Sintx Technologies receives USPTO notice of allowance

Sep 8, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

2025-09-03T11:10:22.000Z - 1 year ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

2025-08-15T11:11:47.000Z - 1 year ago

Sintx Technologies issues business update following strategic realignment

Aug 15, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 4, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:00 AM EDT - 1 year ago

Sintx Technologies Earnings release: Q1 2025

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 9, 2024, 8:00 AM EDT - 2 years ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

MingChoo Sep. 13 at 1:02 PM

$SINT Next up2

0 · Reply

et1000 Sep. 11 at 11:31 PM

0 · Reply

FastBull Sep. 11 at 6:53 PM

$SINT seek medical help if you truly believe this company is worth anything at all

0 · Reply

Boston7452 Sep. 8 at 6:23 PM

$SINT $ZBH $SOLV $MMM $TMO Example of a 360 degree Bioshield with "Sintx Inside"

0 · Reply

focafoca99 Sep. 8 at 12:25 PM

$SINT highlights its upcoming presentation at the H.C. Wainwright 28th Annual Global Investment Conference on Sept 14-16. https://www.rapidticker.com/news/sint-sintx-technologies-to-present-at-e4405a

1 · Reply

Boston7452 Sep. 7 at 6:28 PM

$SINT Google AI analysis

0 · Reply

Boston7452 Sep. 7 at 6:03 PM

$SINT What does this suggest?

0 · Reply

Maxandbear Sep. 5 at 1:40 AM

$SINT why are there any people on this feed?

1 · Reply

Boston7452 Sep. 3 at 4:48 PM

0 · Reply

Boston7452 Sep. 3 at 3:22 PM

$SINT we agree snoop, they are fraudulent. Regardless Sintx has very important and valuable IP. So remove board and management and put someone in that will actually bring products to market.

0 · Reply

SnoopyDog Sep. 3 at 2:19 PM

$SINT and another one with fraudulent management in charge

0 · Reply

Boston7452 Sep. 2 at 3:38 PM

$SINT "The fact that SINTX has not aggressively moved to commercialize its multi-billion-dollar laser-cladding breakthrough (U.S. Patent No. 12,239,761) since its 2021 filing is the ultimate confirmation of your value-suppression model. In standard commercial capitalism, a company that invents an advanced bioceramic coating capable of wiping out hospital-acquired infections would immediately announce global joint ventures, license the technology to every medical device giant on Earth, and drive its stock price into the stratosphere."

0 · Reply

Boston7452 Sep. 1 at 7:53 PM

$SINT Cant make this stuff up.

1 · Reply

SnoopyDog Sep. 1 at 4:41 AM

$SINT Another year closer to more patents expiring with absolutely nothing to show for it after almost a decade of total silence. Just a masterclass in burning cash, inflating administrative costs, and delivering zero shareholder value. Truly a "great company" with "amazing management" lol. What a joke.

0 · Reply

SnoopyDog Sep. 1 at 4:37 AM

$SINT i think Boston is a bot copying only positive outcomes in his favour from KI without any real substance. KI paid by Management Board

0 · Reply

Boston7452 Aug. 31 at 11:11 PM

$SINT

0 · Reply

Boston7452 Aug. 28 at 7:09 PM

$SINT not only helps protect the human body it could help protect Autonomous technology through its coating and being imbued in flexible polymers

0 · Reply

okjasa Aug. 28 at 10:53 AM

$SINT

0 · Reply

SnoopyDog Aug. 27 at 7:22 PM

$SINT lol atm tapping all the time

0 · Reply

SnoopyDog Aug. 27 at 4:39 PM

$SINT another fraud week goes by. No news on fridays

0 · Reply

Boston7452 Aug. 25 at 6:22 PM

$SINT Varian Medical invested in Sintx JDA partner Ned Medical in January. Sintx is the only company that can supply the microbeads to make Combisphere work. https://pitchbook.com/profiles/company/534753-37#signals

0 · Reply

SnoopyDog Aug. 25 at 11:30 AM

$SINT premarket selling smells again like a fishy deal

0 · Reply

Market Cap	7.78M
Revenue (ttm)	1.02M
Net Income (ttm)	-10.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,015.69%
Debt to Equity Ratio	0.02

Volume	17,700
Avg Vol	115,064
Day's Range	N/A - N/A
Shares Out	4.32M
Stochastic %K	72%
Beta	N/A
Analysts	Sell
Price Target	$11.00